iTonic Holdings Ltd. (ITOC)
NCM · Medical Devices
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.
Peers in Medical Devices
All in industry →Abbott Laboratories
Stryker Corporation
Medtronic plc
Boston Scientific Corporation
Edwards Lifesciences Corporation
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
DexCom, Inc.
STERIS plc
Zimmer Biomet Holdings, Inc.
Recent press releases
April 2026
iTonic Holdings Ltd — 6-K Filing
# 🧾 What This Document Is This is a **press release** filed with the SEC as a 6-K report. It’s a formal announcement to investors that iTonic Holdings Ltd has received a critical extension from the Nasdaq stock exchange. Think of it as a " lifeline" notice. # 📢 The Big News: A Compliance Extensio
SEC filings
All filings →Insider trades
All insider trades →iTonic Holdings Ltd. has no reported insider trades in the last 90 days.
Institutional holders
All holders →No 13F holdings have been reported for iTonic Holdings Ltd. in this window.